Business Description
Gabather AB
ISIN : SE0010869552
Compare
Compare
Traded in other countries / regions
GABA.Sweden5J2.Germany IPO Date
2014-11-03Description
Gabather AB is engaged in developing novel drugs to treat several diseases originating in the central nervous system. It has four main focus areas anti-psychotics, anti-depressants and anxiolytics, analgesics, as well as cognition-enhancing treatments, including for Alzheimer's disease.
Financial Strength
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | No Debt | |||||
| Equity-to-Asset | -1.25 | |||||
| Interest Coverage | No Debt | |||||
| Piotroski F-Score | 2/9 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year EBITDA Growth Rate | 16.2 | |||||
| 3-Year EPS without NRI Growth Rate | 16.6 | |||||
| 3-Year FCF Growth Rate | 8.9 | |||||
| 3-Year Book Growth Rate | -74.8 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.65 | |||||
| 9-Day RSI | 47.69 | |||||
| 14-Day RSI | 48.19 | |||||
| 6-1 Month Momentum % | -49.36 | |||||
| 12-1 Month Momentum % | -64.53 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.44 | |||||
| Quick Ratio | 0.44 | |||||
| Cash Ratio | 0.15 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -3.1 | |||||
| Shareholder Yield % | -6.18 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| ROA % | -191.62 | |||||
| ROIC % | -164.4 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| EV-to-EBIT | -1.35 | |||||
| EV-to-EBITDA | -1.35 | |||||
| EV-to-FCF | -1.79 | |||||
| Earnings Yield (Greenblatt) % | -74.12 | |||||
| FCF Yield % | -56.68 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Gabather AB Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | |||
| EPS (TTM) (kr) | -0.636 | ||
| Beta | 0 | ||
| Volatility % | 113.52 | ||
| 14-Day RSI | 48.19 | ||
| 14-Day ATR (kr) | 0.072761 | ||
| 20-Day SMA (kr) | 0.6429 | ||
| 12-1 Month Momentum % | -64.53 | ||
| 52-Week Range (kr) | 0.524 - 4.044444 | ||
| Shares Outstanding (Mil) | 23.72 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 2 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Gabather AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Gabather AB Stock Events
| Event | Date | Price(kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Gabather AB Frequently Asked Questions
What is Gabather AB(OSTO:GABA)'s stock price today?
The current price of OSTO:GABA is kr0.65. The 52 week high of OSTO:GABA is kr4.04 and 52 week low is kr0.52.
When is next earnings date of Gabather AB(OSTO:GABA)?
The next earnings date of Gabather AB(OSTO:GABA) is 2024-11-28.
Does Gabather AB(OSTO:GABA) pay dividends? If so, how much?
Gabather AB(OSTO:GABA) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers